Table 1 Characteristic of studied cohorts.
Center | BD2Decide | Design | MD Anderson | PMH | VUmc | USZ | |
|---|---|---|---|---|---|---|---|
number of patients | 206 | 141 | 110 | 441 | 100 | 176 | |
2 years OS | dead | 55 64% | 36 66% | 0 0% | 96 72% | 31 55% | 40 71% |
alive | 151 36% | 105 34% | 0 0% | 345 28% | 69 45% | 136 29% | |
unknown | 0 0% | 0 0% | 110 100% | 0 0% | 0 0% | 0 0% | |
HPV | positive | 33 16% | 0 0% | 98 89% | 274 62% | 23 23% | 58 33% |
negative | 61 30% | 141 100% | 12 11% | 116 26% | 77 77% | 82 47% | |
unknown | 112 54% | 0 0% | 0 0% | 51 12% | 0 0% | 36 20% | |
Head and neck tumor site | oropharynx | 128 62% | 63 45% | 110 100% | 441 100% | 100 100% | 113 64% |
hypopharynx | 13 6% | 47 33% | 0 0% | 0 0% | 0 0% | 37 21% | |
larynx | 20 10% | 31 22% | 0 0% | 0 0% | 0 0% | 16 9% | |
oral cavity | 45 22% | 0 0% | 0 0% | 0 0% | 0 0% | 10 6% |
